(1)
Dr.Surbhi Kansal; Mainsha Jain. IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC ESBL PRODUCING ENTEROBACTERIACEAE. J Popl Ther Clin Pharmacol 2026, 33 (2), 841-852. https://doi.org/10.69980/1gsrfr34.